Of note, transgenic mice overexpressing galanin showed visceral adiposity, increased body weight, increased serum cholesterol and triglycerides, hyperinsulinemia, and impaired glucose tolerance, indicating that elevated circulating galanin levels contribute to the development of metabolic syndrome (79). This evidence concerns the gene GAL and metabolic syndrome.